Bryant Harbourne

493 total citations
6 papers, 190 citations indexed

About

Bryant Harbourne is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bryant Harbourne has authored 6 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bryant Harbourne's work include Advanced Biosensing Techniques and Applications (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and RNA modifications and cancer (1 paper). Bryant Harbourne is often cited by papers focused on Advanced Biosensing Techniques and Applications (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and RNA modifications and cancer (1 paper). Bryant Harbourne collaborates with scholars based in Canada and United States. Bryant Harbourne's co-authors include William W. Lockwood, Min Hee Oh, Arun M. Unni, Sophia A. Wild, Harold Varmus, S. Elizabeth Franks, Elizabeth C. Halvorsen, Kevin L. Bennewith, Rachel A. Cederberg and Rocky Shi and has published in prestigious journals such as Cancer Research, eLife and Breast Cancer Research.

In The Last Decade

Bryant Harbourne

6 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryant Harbourne Canada 5 95 81 77 20 20 6 190
Sophie Léon France 4 92 1.0× 64 0.8× 54 0.7× 23 1.1× 24 1.2× 4 167
Marina Roy-Luzarraga United Kingdom 5 116 1.2× 101 1.2× 68 0.9× 15 0.8× 24 1.2× 6 227
Magdolna Djurec Spain 3 142 1.5× 85 1.0× 85 1.1× 17 0.8× 22 1.1× 3 211
Marnix Geukes Foppen Netherlands 4 98 1.0× 130 1.6× 82 1.1× 16 0.8× 20 1.0× 8 192
Jane Ho Chun Loong China 4 149 1.6× 64 0.8× 58 0.8× 23 1.1× 59 3.0× 5 257
Daniel Dávila‐González United States 5 54 0.6× 72 0.9× 55 0.7× 23 1.1× 45 2.3× 9 177
Shoukat Afshar‐Sterle Australia 6 74 0.8× 87 1.1× 83 1.1× 15 0.8× 24 1.2× 7 188
Mark Buckup United States 3 57 0.6× 86 1.1× 85 1.1× 25 1.3× 20 1.0× 4 161
Wendy Bindeman United States 5 69 0.7× 137 1.7× 142 1.8× 36 1.8× 20 1.0× 10 264
Su Phyu United States 10 107 1.1× 124 1.5× 73 0.9× 39 1.9× 42 2.1× 20 243

Countries citing papers authored by Bryant Harbourne

Since Specialization
Citations

This map shows the geographic impact of Bryant Harbourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryant Harbourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryant Harbourne more than expected).

Fields of papers citing papers by Bryant Harbourne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryant Harbourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryant Harbourne. The network helps show where Bryant Harbourne may publish in the future.

Co-authorship network of co-authors of Bryant Harbourne

This figure shows the co-authorship network connecting the top 25 collaborators of Bryant Harbourne. A scholar is included among the top collaborators of Bryant Harbourne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryant Harbourne. Bryant Harbourne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Weisser, Nina E., Grant Wickman, Libin Abraham, et al.. (2021). Abstract 1005: The bispecific antibody zanidatamab's (ZW25's) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers. Cancer Research. 81(13_Supplement). 1005–1005. 17 indexed citations
3.
Bosiljcic, Momir, Rachel A. Cederberg, Melisa J. Hamilton, et al.. (2019). Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs. Breast Cancer Research. 21(1). 103–103. 62 indexed citations
4.
O’Farrell, Hannah E., Bryant Harbourne, Zimple Kurlawala, et al.. (2018). Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis. Journal of Thoracic Oncology. 14(4). 656–671. 14 indexed citations
5.
Unni, Arun M., Bryant Harbourne, Min Hee Oh, et al.. (2018). Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells. eLife. 7. 67 indexed citations
6.
Halvorsen, Elizabeth C., S. Elizabeth Franks, Brennan J. Wadsworth, et al.. (2018). IL-33 increases ST2+Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner. OncoImmunology. 8(2). e1527497–e1527497. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026